Full Text View
Tabular View
No Study Results Posted
Related Studies
Hydroxychloroquine + Vorinostat in Advanced Solid Tumors
This study is ongoing, but not recruiting participants.
Study NCT01023737   Information provided by The University of Texas Health Science Center at San Antonio

First Received on July 22, 2009.   Last Updated on July 3, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Malignant Solid Tumour
Additional conditions recognized in this trial
Neoplasms
Interventions listed in this trial
Hydroxychloroquine ( HCQ)
Additional drug interventions recognized in this trial
Hydroxychloroquine
Vorinostat
More general drug interventions related to this trial
Anti-Infective Agents
Antimalarials
Antineoplastic Agents
Antiparasitic Agents
Antiprotozoal Agents
Antirheumatic Agents
Enzyme Inhibitors
Histone Deacetylase Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Devalingam Mahalingam
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services